Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Barrett Esophagus 7Gastroesophageal Reflux 4Adenocarcinoma Of Esophagus 3Stomach Neoplasms 2Weight Loss 1Thrombocythemia, Essential 1Primary Myelofibrosis 1Polycythemia Vera 1Pancreatic Neoplasms 1Neoplasms 1Myeloproliferative Disorders 1Gastrointestinal Neoplasms 1Gastritis, Atrophic 1Esophagitis 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Duodenal Neoplasms 1Deglutition Disorders 1Adenomatous Polyposis Coli 1Adenocarcinoma of the Esophagogastric Junction 1

Interventions

Oxaliplatin 14Fluorouracil 11Capecitabine 9Surveys and Questionnaires 8Leucovorin 8Irinotecan 8Cisplatin 8Bevacizumab 8Standard of Care 5Gemcitabine 5Drug Therapy 4S 1 (combination) 3Radiotherapy 3Nivolumab 3Interviews as Topic 3IFL protocol 3Educational Status 3Cyclophosphamide 3Colonoscopy 3Blood Specimen Collection 35,10-methylenetetrahydrofolic acid 3trebananib 2tivozanib 2pembrolizumab 2Taxes 2Remote Patient Monitoring 2Pemetrexed 2Panitumumab 2Ocoxin 2N-(2-fluoro-4-((2-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)carbonylaminopyridin-4-yl)oxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Gastrointestinal Neoplasms × Endoscopy, Digestive System × Clear all
NCT05107219 2026-04-07

GCC Agonist Signal in the Small Intestine

University of Wisconsin, Madison

Phase 1 Completed
43 enrolled
Gastrointestinal

Barrett Esophagus, Gastroesophageal Reflux, Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡